Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Historical Holders from Q3 2016 to Q3 2025

Symbol
ADPT on Nasdaq
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
152M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
145M
Holdings value
$2.18B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
268
Number of buys
144
Number of sells
-107
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.7% $78.5M 9.94M BlackRock, Inc. 31 Mar 2025
Sumitomo Mitsui Trust Group, Inc. 4.6% $54M 6.83M Sumitomo Mitsui Trust Group, Inc. 31 Dec 2024
Nikko Asset Management Americas, Inc. 4.63% $54M 6.83M Nikko Asset Management Americas, Inc. 31 Dec 2024
INTEGRATED CORE STRATEGIES (US) LLC 4.3% $49.7M 6.29M Millennium Management LLC 31 Dec 2024
Rubric Capital Management LP 4.12% $72.9M 6.26M Rubric Capital Management LP 30 Jun 2025
ARK Investment Management LLC 2.9% -27.3% $40.9M -$15.5M 4.4M -27.5% ARK Investment Management LLC 31 May 2025

Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 145M $2.18B -$14.8M $14.96 268
2025 Q2 148M $1.73B -$46.4M $11.65 240
2025 Q1 153M $1.14B +$68.7M $7.43 222
2024 Q4 143M $859M +$3.88M $6.00 204
2024 Q3 143M $732M -$27.7M $5.12 184
2024 Q2 149M $538M +$26.1M $3.62 173
2024 Q1 142M $457M -$10.2M $3.21 186
2023 Q4 144M $704M +$9.7M $4.90 194
2023 Q3 140M $766M +$15.4M $5.45 187
2023 Q2 137M $920M +$21.9M $6.71 208
2023 Q1 134M $1.18B +$14M $8.83 223
2022 Q4 133M $1.01B +$14.8M $7.64 216
2022 Q3 131M $932M -$31.3M $7.12 205
2022 Q2 134M $1.08B +$49M $8.09 196
2022 Q1 126M $1.74B -$42.4M $13.88 207
2021 Q4 123M $3.46B +$140M $28.06 208
2021 Q3 118M $4B -$434K $33.99 212
2021 Q2 117M $4.8B +$143M $40.86 226
2021 Q1 114M $4.58B -$123M $40.26 238
2020 Q4 114M $6.74B +$149M $59.13 244
2020 Q3 111M $5.41B +$503M $48.63 206
2020 Q2 101M $4.89B +$213M $48.38 192
2020 Q1 96.8M $2.69B +$285M $27.78 144
2019 Q4 86.2M $2.58B +$149M $29.92 129
2019 Q3 81M $2.49B +$38.9M $30.90 116
2019 Q2 78.2M $3.74B +$3.73B $48.30 110
2019 Q1 104K $4.25M $40.86 1
2016 Q4 0 $0 -$10.1K 0
2016 Q3 235 $10.1K +$10.1K $43.05 1